ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,704.00
0.36%
S&P 500
5,214.08
0.51%
US Dollar vs CAD
1.36822
0.03%
Bitcoin
62,855.83
-0.31%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Precision BioSciences Inc (DTIL)

  7. Precision BioSciences Inc (DTIL) News

DTIL

Precision BioSciences (DTIL)

Precision BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DTIL
DateTimeSourceHeadlineSymbolCompany
05/08/20247:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/08/20247:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/08/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/08/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/08/20247:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
05/08/20247:15AMBusiness WirePrecision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private PlacementNASDAQ:DTILPrecision BioSciences Inc
05/07/20243:30PMBusiness WirePrecision BioSciences to Report First Quarter Results on May 13, 2024NASDAQ:DTILPrecision BioSciences Inc
05/07/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/07/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/07/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/07/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/07/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/07/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DTILPrecision BioSciences Inc
05/07/20247:30AMBusiness WirePrecision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) DeficiencyNASDAQ:DTILPrecision BioSciences Inc
05/01/20246:05AMBusiness WirePrecision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024NASDAQ:DTILPrecision BioSciences Inc
04/16/20243:15PMBusiness WirePrecision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail TherapeuticsNASDAQ:DTILPrecision BioSciences Inc
03/27/20245:45AMBusiness WirePrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business UpdateNASDAQ:DTILPrecision BioSciences Inc
03/20/20243:30PMBusiness WirePrecision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024NASDAQ:DTILPrecision BioSciences Inc
03/19/20246:00AMBusiness WirePrecision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial MyopathyNASDAQ:DTILPrecision BioSciences Inc
03/06/20247:45AMBusiness WirePrecision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC DeficiencyNASDAQ:DTILPrecision BioSciences Inc
03/01/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
03/01/20245:30AMBusiness WirePrecision BioSciences Announces $40.0 Million Offering of Common Stock and WarrantsNASDAQ:DTILPrecision BioSciences Inc
03/01/20245:00AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:DTILPrecision BioSciences Inc
02/29/20244:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DTILPrecision BioSciences Inc
02/29/20243:01PMBusiness WirePrecision BioSciences Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:DTILPrecision BioSciences Inc
02/20/20246:00AMBusiness WirePrecision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou BiosciencesNASDAQ:DTILPrecision BioSciences Inc
02/14/20246:00AMBusiness WirePrecision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical ReadinessNASDAQ:DTILPrecision BioSciences Inc
02/13/20247:29AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DTILPrecision BioSciences Inc
02/13/20246:00AMBusiness WirePrecision BioSciences Promotes Naresh Tanna to Vice President of Investor RelationsNASDAQ:DTILPrecision BioSciences Inc
02/12/202410:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DTILPrecision BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:DTIL

Your Recent History

USOTC
EMGE
Emergent Health (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
RDAR
Raadr (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
NVDA
NVIDIA
USOTC
IQST
iQSTEL (QX)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved